These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

154 related items for PubMed ID: 7762389

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Benzalkonium chloride in a decongestant nasal spray aggravates rhinitis medicamentosa in healthy volunteers.
    Graf P, Hallén H, Juto JE.
    Clin Exp Allergy; 1995 May; 25(5):395-400. PubMed ID: 7553241
    [Abstract] [Full Text] [Related]

  • 3. Effect on the nasal mucosa of long-term treatment with oxymetazoline, benzalkonium chloride, and placebo nasal sprays.
    Graf P, Hallén H.
    Laryngoscope; 1996 May; 106(5 Pt 1):605-9. PubMed ID: 8628089
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Ten days' use of oxymetazoline nasal spray with or without benzalkonium chloride in patients with vasomotor rhinitis.
    Graf P, Enerdal J, Hallén H.
    Arch Otolaryngol Head Neck Surg; 1999 Oct; 125(10):1128-32. PubMed ID: 10522506
    [Abstract] [Full Text] [Related]

  • 7. Correlation between objective nasal mucosal swelling and estimated stuffiness during long-term use of vasoconstrictors.
    Graf P, Juto JE.
    ORL J Otorhinolaryngol Relat Spec; 1994 Oct; 56(6):334-9. PubMed ID: 7530821
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Histamine sensitivity in the nasal mucosa during four-week use of oxymetazoline.
    Graf P, Juto JE.
    Rhinology; 1994 Sep; 32(3):123-6. PubMed ID: 7839081
    [Abstract] [Full Text] [Related]

  • 10. Long-term use of oxy- and xylometazoline nasal sprays induces rebound swelling, tolerance, and nasal hyperreactivity.
    Graf P.
    Rhinology; 1996 Mar; 34(1):9-13. PubMed ID: 8739860
    [Abstract] [Full Text] [Related]

  • 11. One year follow-up of patients with rhinitis medicamentosa after vasoconstrictor withdrawal.
    Graf PM, Hallén H.
    Am J Rhinol; 1997 Mar; 11(1):67-72. PubMed ID: 9065350
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Oxymetazoline nasal spray three times daily for four weeks in normal subjects is not associated with rebound congestion or tachyphylaxis.
    Watanabe H, Foo TH, Djazaeri B, Duncombe P, Mackay IS, Durham SR.
    Rhinology; 2003 Sep; 41(3):167-74. PubMed ID: 14579657
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Use of mometasone furoate aqueous nasal spray in the treatment of rhinitis medicamentosa: an experimental study.
    Tas A, Yagiz R, Yalcin O, Uzun C, Huseyinova G, Adali MK, Karasalihoglu AR.
    Otolaryngol Head Neck Surg; 2005 Apr; 132(4):608-12. PubMed ID: 15806055
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.